Kinaxis Inc (KXS) Receives C$103.25 Consensus PT from Brokerages

Share on StockTwits

Kinaxis Inc (TSE:KXS) has earned an average rating of “Buy” from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is C$102.94.

A number of equities analysts recently weighed in on the company. CIBC raised their price objective on Kinaxis from C$101.00 to C$107.00 in a report on Monday, August 27th. Royal Bank of Canada raised their price objective on Kinaxis from C$105.00 to C$110.00 and gave the company an “outperform” rating in a report on Monday, September 10th. BMO Capital Markets raised their price objective on Kinaxis from C$93.00 to C$105.00 and gave the company an “outperform” rating in a report on Tuesday, August 7th. TD Securities raised their price objective on Kinaxis from C$98.00 to C$105.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. Finally, Eight Capital raised their price objective on Kinaxis from C$100.00 to C$105.00 in a report on Tuesday, August 7th.

Shares of TSE KXS opened at C$74.03 on Wednesday. The company has a quick ratio of 2.77, a current ratio of 2.84 and a debt-to-equity ratio of 7.77. Kinaxis has a 1-year low of C$69.59 and a 1-year high of C$100.68.

In other Kinaxis news, Director John Ernest Sicard sold 5,000 shares of Kinaxis stock in a transaction that occurred on Monday, August 13th. The stock was sold at an average price of C$98.00, for a total value of C$490,000.00.

About Kinaxis

Kinaxis Inc provides cloud-based software for supply chain operations. The company offers RapidResponse, which provides supply chain planning and analytics capabilities for managing various supply chain management processes, including supply planning, inventory management, order fulfillment, capacity planning, and master scheduling, as well as sales and operations planning process.

See Also: Understanding Stock Ratings

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.